Latest News for WM Tech Stock (NASDAQ:MAPSW)

WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business.

WM Technology Inc

Commodities

Markets

Chevron's Production In Venezuela Increased To 180,000 Barrels/Day

Stifel analyst Stanley Elliott maintains United Rentals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) with a Buy and raises the price target from $720 to $750.

News

Price Target

Analyst Ratings

Stifel Maintains Buy on United Rentals, Raises Price Target to $750

Dividends

Kellanova Board Plans To Increase Dividend From $0.56 To $0.57/Share Beginning In Q3

Stifel analyst Shlomo Rosenbaum maintains TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) with a Buy and raises the price target from $83 to $92.

Stifel Maintains Buy on TransUnion, Raises Price Target to $92

The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CBSTF#OTCQX">CBSTF</a>) (FSE: 3LP) announced on Friday its latest expansion with Airo Brands, a multi-state cannabis company focused on proprietary, cutting-edge vapor delivery platforms and high-quality oils, into Virginia and Pennsylvania.
"Expanding into Virginia and Pennsylvania underscores our commitment to providing the highest quality products and demonstrates the precision and expertise of The Cannabist Company to create consistent experiences across multiple markets, which is critical for developing brand equity," said Volley Hayhurst, vice president of operations at the New York-based company.
See also: <a href="https://www.benzinga.com/markets/cannabis/24/03/37470616/evolving-cannabis-retail-the-cannabist-companys-rebranding-strategy-unveiled">Evolving Cannabis Retail: The Cannabist Company&#8217;s Rebranding Strategy Unveiled</a>
The Cannabist Company initiated a partnership with Airo Brands last year, marking a considerable development in cannabis vaporization available within its dispensaries, <a href="https://www.benzinga.com/markets/cannabis/23/11/35897828/new-collab-is-taking-weed-vaping-in-delaware-to-next-level">starting with three locations in Delaware.</a> Additional partnership expansion introduced Airo's vaporizing experience to West Virginia in March.
"Our ongoing partnership with Richard and the Airo team has been a tremendous success, allowing us to provide reliable and exceptional products to our patients and customers looking for a smooth and enjoyable vaping experience," Hayhurst added.
The Cannabist Company launched Airo's vapor systems, including the AiroPro and AiroSport batteries, and AiroX All-In-One, as well as its AiroPod cartridge oil formulations at its Cannabist and gLeaf dispensaries in Virginia as well as its Columbia Care locations in Pennsylvania. Airo is also available through the company's wholesale channels in both markets.
Now read: <a href="https://www.benzinga.com/markets/cannabis/24/04/38202454/new-multi-state-partnership-to-attract-customers-seeking-chic-quality-cannabis-products">New Multi-State Partnership To &#8216;Attract Customers Seeking Chic, Quality Cannabis Products&#8217;</a>

Cannabis

Retail Sales

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

CBSTF

New York Weed Giant's Collab With Airo Brings Cannabis Vaping To Next Level In These Two States

Vincerx Pharma Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) shares are trading lower by 9.7% to $0.81 during Friday&#8217;s session after the company priced an <a href="https://investors.vincerx.com/news-releases/news-release-details/vincerx-pharma-announces-pricing-underwritten-public-offering">underwritten public offering</a>, including 6 million shares of common stock with accompanying warrants to purchase the same number of shares, and pre-funded warrants for up to 16 million shares with accompanying warrants for the same amount.
The combined public offering price for each share and accompanying warrant is $0.75, and for each pre-funded warrant and accompanying warrant, it is $0.7499. The pre-funded warrants have an exercise price of $0.0001 per share and can be exercised immediately until fully exercised, while the common stock warrants have an exercise price of $1.00 per share and expire five years from the date of issuance. 
The offering is expected to raise approximately $16.5 million for Vincerx before expenses and is set to close around April 30, pending customary closing conditions. Leerink Partners is the sole bookrunning manager for the offering.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38463199/dan-ives-says-ai-is-the-fourth-industrial-revolution-after-robust-results-from-micr">Dan Ives Says AI Is The &#8216;Fourth Industrial Revolution&#8217; After &#8216;Robust&#8217; Results From Microsoft And Google: &#8216;1995 Moment&#8217;</a>
<h2 class="wp-block-heading">Should I Sell My VINC Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Shares of Vincerx Pharma have lost 38.13% year to date. This compares to the average annual return of -62.46%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. 
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Vincerx Pharma stock currently has an RSI of 42.77, indicating neutral conditions.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
SOFI has a 52-week high of $9.37 and a 52-week low of $0.61.

VINC

Why Vincerx Pharma (VINC) Stock Is Falling

Stifel analyst David Grossman maintains Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) with a Hold and lowers the price target from $21 to $16.

TDOC

Stifel Maintains Hold on Teladoc Health, Lowers Price Target to $16

Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) has outperformed the market over the past 5 years by 23.27% on an annualized basis producing an average annual return of 34.83%. Currently, Lam Research has a market capitalization of $120.82 billion. 
Buying $1000 In LRCX: If an investor had bought $1000 of LRCX stock 5 years ago, it would be worth $4,483.72 today based on a price of $924.18 for LRCX at the time of writing.
<h3>Lam Research's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714145431_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

LRCX

$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,500 Today

Ascendis Pharma's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NYSE">ASND</a>) short percent of float has risen 13.75% since its last report. The company recently reported that it has 3.35 million shares sold short, which is 8.52% of all regular shares that are available for trading. Based on its trading volume, it would take traders 11.64 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ascendis Pharma Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714145425_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ascendis Pharma has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ascendis Pharma's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ascendis Pharma's peer group average for short interest as a percentage of float is 4.96%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

ASND

Looking Into Ascendis Pharma's Recent Short Interest

S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) has outperformed the market over the past 10 years by 8.41% on an annualized basis producing an average annual return of 18.85%. Currently, S&amp;P Global has a market capitalization of $130.41 billion. 
Buying $100 In SPGI: If an investor had bought $100 of SPGI stock 10 years ago, it would be worth $563.38 today based on a price of $416.51 for SPGI at the time of writing.
<h3>S&amp;P Global's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714145425_0_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SPGI

Here's How Much $100 Invested In S&P Global 10 Years Ago Would Be Worth Today

VF's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) short percent of float has risen 13.22% since its last report. The company recently reported that it has 34.05 million shares sold short, which is 9.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>VF Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714145419_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for VF has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing VF's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, VF's peer group average for short interest as a percentage of float is 7.80%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About VF?

Medifast's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) short percent of float has risen 29.89% since its last report. The company recently reported that it has 2.66 million shares sold short, which is 37.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.6 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Medifast Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714145414_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Medifast has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Medifast's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Medifast's peer group average for short interest as a percentage of float is 4.61%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Medifast?

Stephens &amp; Co. analyst Terry McEvoy reiterates Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) with a Equal-Weight and maintains $23 price target.

Reiteration

Stephens & Co. Reiterates Equal-Weight on Associated Banc, Maintains $23 Price Target

Stifel analyst Mark Kelley maintains Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) with a Hold and raises the price target from $12 to $13.

SNAP

Stifel Maintains Hold on Snap, Raises Price Target to $13

Stifel analyst Shlomo Rosenbaum maintains S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) with a Buy and raises the price target from $442 to $446.

Stifel Maintains Buy on S&P Global, Raises Price Target to $446

Chevron Not Affected By Recent Sanctions, But Not Putting New Capital In Venezuela

Biotech

General

UPDATE: IGC Pharma Announces Interim Results For IGC-AD1 In Reducing Alzheimer's Agitation; Results Indicate That IGC-AD1 Clinically Reduced Agitation Compared To Placebo, Was Previously Announced On March 20, 2024

Stifel analyst Jim Duffy maintains Revolve Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) with a Buy and raises the price target from $20 to $24.

RVLV

Stifel Maintains Buy on Revolve Gr, Raises Price Target to $24

Stephens &amp; Co. analyst John Campbell reiterates AppFolio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPF#NASDAQ">APPF</a>) with a Overweight and maintains $241 price target.

APPF

Stephens & Co. Reiterates Overweight on AppFolio, Maintains $241 Price Target

iClick Interactive Asia Group Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) shares are trading lower by 54.5% to $1.15 during Friday&#8217;s session after the company announced the termination of its <a href="https://www.benzinga.com/pressreleases/24/04/n38457411/iclick-interactive-asia-group-limited-announces-termination-of-merger-agreement">merger agreement</a> with TSH Investment Holding Limited and TSH Merger Sub Limited. 
Despite fulfilling the necessary conditions and indicating readiness to proceed with the closing, the Parent and Merger Sub did not finalize the process within the specified timeframe. 
In response, iClick, acting upon the recommendation of a Special Committee, has exercised its right to terminate the agreement. They have demanded a termination fee of $1.8 million from the Parent. This termination means that the proposed merger will not move forward as originally planned.
See Also: <a href="https://www.benzinga.com/general/macro-notification/24/04/38458581/feds-key-inflation-indicator-hits-2-8-dashes-rate-cut-hopes-traders-on-alert">Fed&#8217;s Key Inflation Indicator Hits 2.8%, Dashes Rate Cut Hopes; Traders On Alert</a>
<h2 class="wp-block-heading">Should I Sell My ICLK Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Shares of iClick Interactive Asia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) have lost 60.91% year to date. This compares to the average annual return of -73.01%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. 
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. iClick Interactive Asia stock currently has an RSI of 14.26, indicating oversold conditions.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, SOFI has a 52-week high of $4.01 and a 52-week low of $1.06.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for WM Tech Stock (NASDAQ:MAPSW)

People Also Watch